Russia’s API market | Growth | Trends | Progress | Challenges | Opportunities & Forecast to 2020 |
Market Entry - Active Pharmaceutical Ingredients (API) Industry in Russia: Analysis of Growth, Trends and Progress (2016 - 2021)

PUBLISHED

DEC 2017

Market Entry - Active Pharmaceutical Ingredients (API) Industry in Russia: Analysis of Growth, Trends and Progress (2016 - 2021)

Purchase Report

About the Market

The API market is surging due to the increased demand for pharmaceutical drugs, which in turn is driven by the aging population, rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular, neurological and infectious diseases. India and China are the major suppliers of APIs to North America due to their low production capacities, labor costs and the presence of a large number of global and domestic players. In order to cut down on expenses and increase profits, companies have begun outsourcing the creation of APIs to the developing countries in Asia, leading to growth in the Asian market. The safety of medication APIs are subject to stringent regulations and oversight from the country they are shipped to. Teva Pharmaceuticals Limited, Sun Pharmaceuticals Industries Limited, Dr. Reddy’s Laboratories Ltd., and Aurobindo are some key players in the market.

About the Geography

Russia is the largest country in terms of area and has a democratic government with a very strong president. Russia has undergone significant changes since the collapse of the Soviet Union, moving from a centrally planned economy towards a more market-based system. The economy, which had averaged 7% growth during 1998-2008 as oil prices rose rapidly, has seen diminishing growth rates since then due to exhaustion of Russia’s commodity-based growth model.

Russia is seeking to develop in an adverse political and economic environment. The government is trying to transition from an economy based on oil and raw material extraction to an economy based on technology. To achieve this, continual improvement of the attractiveness of investment in Russia remains one of the government’s key strategies. As a part of this, they have created special economic zones, ‘advanced development’ territories, and developed tax incentive systems.

The Russian economy is going through a difficult period with international sanctions, drop in oil prices and other limitations. The major challenges for doing business include the vastness of the country, which means different levels of economic and social factors, high levels of corruption and extreme climatic conditions. The Russian economy is trying to get rid of inefficiencies at all levels including government spending and there is an enormous push for localization of production to diversify the economy.

 

                Component Name               

Unit

From Site

GDP

USD billion

1326

GDP Annual Growth Rate

%

-0.6

GDP Per Capita

USD

11039

Employment Rate

%

66.6

Wages

USD/Month

545.247

Inflation Rate

%

6.4

Consumer Price Index (CPI)

Index Points

531

Interest Rate

%

10

Loans to Private Sector

USD million/billion

350,554.26 million

Balance of Trade

USD million/billion

6490 million

Business Confidence

(No Units)

-5

Manufacturing PMI

Index Points

51.1

Ease of Doing Business

(No Units)

51

Competitiveness Rank

(No Units)

43

Corruption Rank

(No Units)

119

Consumer Confidence

(No Units)

-19

Consumer Spending

USD million/billion

113.711 billion

Bank Lending Rate (Consumers)

%

12.53

Corporate Tax Rate

%

20

Sales Tax Rate

%

18

 

The Market Entry Series

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.

1. Introduction

                1.1 Scope of the Report

                1.2 Regional Analysis

                                1.2.1 PESTLE Analysis

                                1.2.2 Analysis of Ease of Doing Business

2. Market Dynamics

                2.1 Drivers

                2.2 Restraints

                2.3 Opportunities

3. Market Demand Analysis

                3.1 Socio-Economic Segmentation

                3.2 Demographic Strengths & Weaknesses

                3.3 Spending Patterns

                3.4 Target Market Identification

4. Market Size of Adjuvant Industry (USD millions)

                4.1 By Types of Inorganic Compounds

                4.2 By Bacterial Products

5. Market Entry

                5.1 Market Entry: The Strategy

                                5.1.1 Types of Entry Modes, by Market Entry Objectives

                                5.1.2 Competition Analysis

                                                5.1.2.1 Market Share

                                                5.1.2.2 Strategies Adopted, Recent Events 

                                5.1.3 Pricing Strategy

                                5.1.4 Supply Chain Analysis

                                                5.1.4.1 Trade (Import-Export Analysis)

                                                5.1.4.2 Distribution Network & Retail Analysis

                5.2 Market Entry: The Administration

                                5.2.1 How to Register a Company (Flowchart)

                                5.2.2 Registration Processes 

                                                5.2.2.1 Ministries Involved

                                                5.2.2.2 Criteria and Conditions

                                5.2.3 List of Forms & Documents

                                5.2.4 Product Control Guidelines specified by the Government

6. Sources

7. Disclaimer

Purchase Report

Our Clients Include View All

Looking to Customize Report?